Aldeyra CFO Joshua Reed resigns; Bruce Greenberg named interim CFO

Aldeyra Therapeutics, Inc.

Joshua Reed resigns as CFO and Treasurer effective May 10, 2022, to pursue other opportunities.
Bruce Greenberg, current VP and Controller, appointed Interim CFO and Treasurer.
Greenberg has over 25 years of accounting experience; previously Corporate Controller at Karyopharm Therapeutics.
Reed will assist transition and participate in Aldeyra's Q1 2022 earnings call.
No disputes with management or board regarding Reed's resignation.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joshua Reed

Chief Financial Officer

ALDX · Aldeyra Therapeutics, Inc.

Effective: 2022-05-10
Successor: Bruce Greenberg
Filed: April 28, 2022, 7:59 PM ET

On April 25, 2022, Joshua Reed notified Aldeyra Therapeutics, Inc. (the “Company”) of his intent to resign as the Company’s Chief Financial Officer and Treasurer.

Appointed (interim)

Bruce Greenberg

Interim Chief Financial Officer

ALDX · Aldeyra Therapeutics, Inc.

Effective: 2022-05-10
Filed: April 28, 2022, 7:59 PM ET

Effective as of the Resignation Date, the Company plans to appoint Bruce Greenberg to serve as its Vice President of Finance, Interim Chief Financial Officer, and Treasurer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Joshua Reed resigned as Chief Financial Officer at Aldeyra Therapeutics, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On April 25, 2022, Joshua Reed notified Aldeyra Therapeutics, Inc. (the “Company”) of his intent to resign as the Company’s Chief Financial Officer and Treasurer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Bruce Greenberg was appointed as Interim Chief Financial Officer at Aldeyra Therapeutics, Inc..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

Effective as of the Resignation Date, the Company plans to appoint Bruce Greenberg to serve as its Vice President of Finance, Interim Chief Financial Officer, and Treasurer.

View on SEC.gov

Aldeyra Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001157523-22-000502

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.